SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-060683
Filing Date
2023-11-08
Accepted
2023-11-08 07:30:30
Documents
79
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q beam-20230930.htm   iXBRL 10-Q 3012845
2 EX-31.1 beam-ex31_1.htm EX-31.1 19350
3 EX-31.2 beam-ex31_2.htm EX-31.2 19392
4 EX-32.1 beam-ex32_1.htm EX-32.1 11001
5 EX-32.2 beam-ex32_2.htm EX-32.2 11032
  Complete submission text file 0000950170-23-060683.txt   11237987

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT beam-20230930.xsd EX-101.SCH 64504
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT beam-20230930_def.xml EX-101.DEF 281014
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT beam-20230930_cal.xml EX-101.CAL 50115
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT beam-20230930_pre.xml EX-101.PRE 433327
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT beam-20230930_lab.xml EX-101.LAB 494166
73 EXTRACTED XBRL INSTANCE DOCUMENT beam-20230930_htm.xml XML 2343622
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Filer) CIK: 0001745999 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39208 | Film No.: 231385959
SIC: 2836 Biological Products, (No Diagnostic Substances)